Skip to main content
Category

Uncategorized

BHI Supports UMD Inventors

By Uncategorized

As part of the University of Maryland’s 26th Annual Invention of the Year Awards ceremony held at the University of Maryland Golf Course on April 16, BioHealth Innovation sweetened the pot for this year’s three award winners. BHI offered each award winner strategic consulting services on federal grants or SBIR awards – valued at $2,500 per company. The BHI Commercial Relevance Program is designed to support small businesses in commercializing their technological research efforts.

The three winning inventions were:
INFORMATION SCIENCE CATEGORY:
Winner:
Time-Reversal Division Multiple Access for Wireless Broadband Communications
Feng Han, Yu-Han Yang, Beibei Wang, Yongle Wu and K. J. Ray Liu

LIFE SCIENCE CATEGORY:
Winner:
A Method for Early Diagnosis of Amyotrophic Lateral Sclerosis (ALS)
Eva Chin and Dapeng Chen

PHYSICAL SCIENCE CATEGORY:
Winner:
A Method for Rapid, Inexpensive Prototyping of Microfluidic Devices
Omid Rahmanian, Donald DeVoe

More Information

biotech-success

Montgomery County and BHI at BIO 2013, Booth 1423

By Uncategorized

biotech-success

The Montgomery County Department of Economic Development and our partner, BioHealth Innovation, Inc., invite you to visit us at Booth 1423, the Maryland Pavilion, during the BIO International Convention in Chicago, April 22 – 25.

Nearly 50 Montgomery County biotech companies, organizations, or public sector entities will attend. Twenty-six Maryland organizations, companies or public-sector entities will be represented in the Maryland Pavilion, Booth 1423, including the following from Montgomery County:

Read More
umd-a-james-clark-engineering

Clark School Faculty Recognized at UMD Invention of the Year Awards

By Uncategorized

umd-a-james-clark-engineering

Time-reversal techniques for optimizing broadband communication networks and rapid prototyping of microfluidics devices were among the Clark School of Engineering inventions recognized as the most promising new technologies at the University of Maryland Invention of the Year Awards.

The University of Maryland’s Office of Technology Commercialization (OTC) hosted the 26th Annual Invention of the Year Awards reception on Tuesday, April 16, 2013 from 4:30-6:00 pm at the University of Maryland Golf Course Club House.

Read More
Malone

Serial Entrepreneur Ken Malone Named BHI Entrepreneur-in-Residence to Offer Commercialization Guidance to Start-Ups Based on UM Discoveries

By Uncategorized

MaloneBioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, today announced its selection of Ken Malone, Ph.D., of Early Charm Ventures, as the first BHI Entrepreneur-in-Residence (EIR) assigned to work directly with UM Ventures. Dr. Malone, a serial entrepreneur who has founded or been an officer of five biotechnology or advanced materials companies, will help advance the commercialization efforts of new start-up companies based upon innovative discoveries coming out of research programs at the University of Maryland (UMD) College Park and Baltimore.

“We’re thrilled to name Ken Malone as an EIR,” said Richard Bendis, BHI President & CEO. “Ken and I have a long history of working together, so I know first hand that he has the experience, drive and perspective to be a true asset to BHI and to the many start-ups he’ll serve from University of Maryland in support of the newly launched UM Ventures initiative.” Dr. Malone will assist any interested UM start-ups once they have been launched.

Read More

Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44) – Jun 19, 2015

By Uncategorized

Funding Opportunity Number: RFA-HL-14-012
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
CFDA Number: 93.233
93.350
93.837
93.838
Eligible Applicants Small businesses
Agency Name: HHS-NIH11
Closing Date: Jun 19, 2015
Award Ceiling:
Expected Number of Awards:
Creation Date: Apr 16, 2013
Funding Opportunity Description: The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is to de-risk these technologies so that development can continue with private funding after NHLBI support ends; therefore, applicants must submit a Commercialization Plan, which should include details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=230693

Read More
bhi-um-ventures-logos

Visisonics Named First UM Ventures Start-Up Prize Winner

By Uncategorized

– Technology Company Awarded Prize at Invest Maryland Challenge Ceremony –

bhi-um-ventures-logosBALTIMORE, MD, April 16, 2013University of Maryland (UM) Ventures, an ambitious joint research commercialization effort of the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP), announced today that it has awarded the first UM Ventures Start-Up Prize to VisiSonics, an Investment Maryland Challenge Semi Finalist company that was founded on intellectual property owned by the University. VisiSonics was recognized during the Invest Maryland Challenge Award Ceremony on Monday, April 15, 2013 at the Maryland Institute College of Art (MICA) in Baltimore, Maryland.

“Identifying customers and having sales is, of course, a major hurdle for university start-ups,” said James L. Hughes, Director of UM Ventures, and President, Research Park Corporation, University of Maryland Baltimore. “With the significance of achieving more than half a million dollars in sales in 2012, VisiSonics is a worthy recipient of this inaugural prize.”

Read More

Revision Applications to U01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (U01) – Dec 11, 2015

By Uncategorized

Funding Opportunity Number: PAR-13-176
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
CFDA Number: 93.394
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: Dec 11, 2015
Award Ceiling: $150,000
Expected Number of Awards:
Creation Date: Apr 11, 2013
Funding Opportunity Description: This Funding Opportunity Announcement (FOA) invites cooperative agreement research (U01) revision applications from investigators with active NIH U01 research project awards. Revision applications are expected to focus on combined imaging and biomarker approaches to improve screening, early cancer detection and diagnosis by integrating multi modality imaging strategies and multiplexed biomarker methodologies. Studies proposed in the revision applications must correspond to additional specific aims, expanding the scope of individual, already funded parent U01 Cooperative Agreements.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=230198

Read More

Mechanisms of Alcohol and Nicotine Co-Addiction (R21) – Sep 07, 2016

By Uncategorized

Funding Opportunity Number: PA-13-193
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
CFDA Number: 93.273
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: Sep 07, 2016
Award Ceiling: $200,000
Expected Number of Awards:
Creation Date: Apr 12, 2013
Funding Opportunity Description: This FOA encourages R21 applications from institutions/organizations that propose to study neurobiological and behavioral mechanisms contributing to concurrent alcohol and nicotine co-addiction.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=230353

Read More

NIDCD Research On Hearing Health Care (R21/R33) – Feb 24, 2015

By Uncategorized

Funding Opportunity Number: RFA-DC-14-001
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
CFDA Number: 93.173
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: Feb 24, 2015
Award Ceiling:
Expected Number of Awards:
Creation Date: Apr 15, 2013
Funding Opportunity Description: This funding opportunity announcement (FOA) invites Exploratory/Developmental Phased Innovation (R21/R33) grant applications to support research and/or infrastructure needs leading to more accessible and affordable hearing health care (HHC). The proposed research aims should lead to the delivery of better healthcare access and outcomes and be directed to solutions that are effective, affordable and deliverable to those who need them. Outcomes and health services research are also responsive to this FOA. This FOA provides support for up to two years (R21 phase) for preliminary/development studies, followed by possible transition of up to four years of expanded research and development support (R33 phase). The total project period for an application submitted in response to this FOA may not exceed five years. This FOA requires measurable R21 milestones.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=230555

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.